Anti-NGF monoclonal Antibodies for Controlling Canine OA Pain - Understanding the Science and Involving the Full Team

RACE-approved free webinar sponsored by Zoetis. 

Monoclonal antibodies (mAbs) are the latest class of drugs to be approved for controlling OA pain. In this lecture we provide the science behind the mAbs developed for canine OA pain, including the clinical efficacy and safety data. After presenting the scientific details of the mAb, Dr Petty will then discuss how to involve the entire team, including the pet owner, the front office staff, technicians and veterinarians in the diagnosis, communication and management of canine OA pain.